Clinical experiences with cannabinoids in spasticity management in multiple sclerosis

Interrater Reliability of a Modified Ashworth Scale of Muscle Spasticity

Richard W. Bohannon, Melissa B. Smith · Physical Therapy · 1987 · 5.4K citations

Medicine, Neurology, Orthopedic Surgery +14

Prevalence and treatment of spasticity reported by multiple sclerosis patients

Marco Rizzo, Olympia Hadjimichael, Jana Lízrová Preiningerová et al. · Multiple Sclerosis Journal · 2004 · 540 citations

Pharmacy, Neurology, Pharmacotherapy +17

A randomized, double-blind, placebo-controlled, parallel-group, enriched-design study of nabiximols* (Sativex^®), as add-on therapy, in subjects with refractory spasticity caused by multiple sclerosis

Alena Novotná, Jan Mareš, S. Ratcliffe et al. · European Journal of Neurology · 2011 · 464 citations

Medicine, Neurology, Pharmacology +17

Stop using the Ashworth Scale for the assessment of spasticity

J F M Fleuren, G Voerman, Cathelijne V. Erren-Wolters et al. · Journal of Neurology Neurosurgery & Psychiatry · 2009 · 431 citations · Full text

Medicine, Neurology, Rehabilitation Medicine +15

A placebo-controlled, parallel-group, randomized withdrawal study of subjects with symptoms of spasticity due to multiple sclerosis who are receiving long-term Sativex® (nabiximols)

William Notcutt, R. M. Langford, Paul Davies et al. · Multiple Sclerosis Journal · 2011 · 158 citations · Full text

Medicine, Neurology, Pharmacology +16